+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening



Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening



Molecular Cancer Therapeutics 8(3): 563-570



Colorectal cancer is one of the leading causes of cancer mortality and morbidity worldwide. Previous studies indicate that the zinc finger-containing transcription factor Krüppel-like factor 5 (KLF5) positively regulates proliferation of intestinal epithelial cells and colorectal cancer cells. Importantly, inhibition of KLF5 expression in intestinal epithelial cells and colorectal cancer cells by pharmacologic or genetic means reduces their rate of proliferation. To identify additional and novel small molecules that inhibit KLF5 expression and thus colorectal cancer proliferation, we developed a reporter assay using colorectal cancer cell line (DLD-1) that stably expressed a luciferase reporter gene directed by 1,959 bp of the human KLF5 promoter upstream of the ATG start codon and performed a cell-based high-throughput screen with the Library of Pharmacologically Active Compounds that contains 1,280 biologically active compounds. The screen identified 8 potential inhibitors and 6 potential activators of the KLF5 promoter. Three potential inhibitors, wortmannin, AG17, and AG879, were further evaluated by secondary analyses. All three significantly reduced both KLF5 promoter-luciferase activity and protein level in DLD-1 cells in a dose- and time-dependent manner when compared with controls. They also significantly reduced the rate of proliferation of DLD-1 and two other colorectal cancer cell lines, HCT116 and HT29. Our results show the principle of using high-throughput screening to identify small-molecule compounds that modulate KLF5 activity and consequently inhibit colorectal cancer proliferation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053669052

Download citation: RISBibTeXText

PMID: 19240162

DOI: 10.1158/1535-7163.mct-08-0767


Related references

Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screening. Molecular Cancer Therapeutics 10(11): 2043-2051, 2012

W1952 Identification of Novel Small Molecule Compounds That Inhibit the Pro-Proliferative KrPpel-Like Factor 5 By High-Throughput Screening. Gastroenterology 134(4): A-741, 2008

Tu1894 Ultrahigh-Throughput Screening Strategies for Identification of Small-Molecule Compounds That Target the Colon Cancer Oncogene KrPpel-Like Factor 5. Gastroenterology 144(5): S-874, 2013

High-throughput small molecule screening reveals structurally diverse compounds that inhibit the growth of Escherichia coli O157:H7 in vitro. Journal of Food Protection 74(12): 2148-2156, 2012

Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening. Journal of Neuroscience Research 89(1): 58-72, 2011

High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer. Future Oncology 8(3): 259-272, 2012

High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Analytical Biochemistry 320(1): 66-74, September 1, 2003

Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries. Nucleic Acids Research 2018, 2018

Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays. Molecules 24(5), 2019

A high throughput screening assay system for the identification of small molecule inhibitors of gsp. Plos One 9(3): E90766, 2015

Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening. 2013

High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Research 134: 6-16, 2016

Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening. Cancer Science 104(11): 1461-1467, 2014

Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure. Naunyn-Schmiedeberg's Archives of Pharmacology 387(1): 5-14, 2014

High Throughput Screening for Colorectal Cancer Specific Compounds. Combinatorial Chemistry and High Throughput Screening 19(3): 180-188, 2016